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ABSTRACT 
RECREATIONAL PHYSICAL ACTIVITY AND PREMENSTRUAL SYNDROME IN 
COLLEGE-AGED WOMEN 
MAY 2010 
AIMEE KROLL, B.A., MOUNT HOLYOKE COLLEGE 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST  
Directed by: Professor Elizabeth R. Bertone-Johnson 
 
It is estimated that up to 85% of premenopausal women experience at least one 
premenstrual symptom and 15-20% meet clinical criteria for premenstrual syndrome 
(PMS). PMS has a high morbidity level and reduces the quality of life for many women 
of reproductive age, with pharmaceutical treatments having limited efficacy and 
substantial side effects. Physical activity has been recommended as a method of reducing 
menstrual symptom severity. However, little evidence exists to support a clear 
relationship between physical activity and PMS.  Using a cross-sectional design, we 
evaluated the relationship between physical activity and PMS and menstrual symptoms 
among 186 women aged 18-30 who participated in the University of Massachusetts 
Vitamin D Study.  PMS and menstrual symptoms were assessed with a modified version 
of the Calendar of Premenstrual Experiences.  A total of 44 women met established 
criteria for PMS, while 46 met criteria for controls.  Physical activity was assessed using 
a validated questionnaire similar to the one used in the Nurses’ Health Study II.  Physical 
activity was calculated as metabolic equivalent task-hours (METs) per week.  Diet and 
other lifestyle factors were assessed by questionnaire.  After adjusting for age and 
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depression diagnosis, we found that each 10 MET-hour/week increase in physical activity 
was associated with a non-significant 3% increase in prevalence of PMS (95% CI: 0.94-
1.14). After adjusting for BMI and percent body fat, results were similar (OR=1.02, 95% 
CI: 0.93-1.13).  We found no evidence that physical activity was associated with the 
occurrence of specific menstrual symptoms among all 186 women. Results do not 
support a significant relationship between physical activity and prevalent PMS. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
 Premenstrual syndrome (PMS) is a condition occurring in the luteal phase of the 
menstrual cycle prior to the onset of a woman’s menstrual period.  It is estimated that up 
to 85% of women who menstruate experience at least one premenstrual symptom, 
occurring within the two weeks before menses and easing after menstruation begins.1 
PMS is estimated to occur in 8-20% of women and substantially reduces quality of life.2-4 
Over 300 PMS symptoms have been described,5 ranging from emotional and behavioral 
symptoms such as depression, angry outbursts, irritability, crying spells, anxiety, 
confusion, social withdrawal, poor concentration, sleep disturbance, and thirst and 
appetite changes, to physical symptoms including breast tenderness, bloating and weight 
gain, headache, swelling of the hands or feet, and aches or pains.1   
 The causes of PMS are not clear.  PMS is thought to be caused by an underlying 
neurobiological vulnerability to normal fluctuations in the circulating sex hormones 
estrogen and progesterone levels during the menstrual cycle.6,7 The role of sex steroids in 
PMS is supported by observations that symptoms often improve with treatments resulting 
in ovulation suppression.6  In addition, studies suggest that PMS is uncommon in 
anovulatory menstrual cycles, and that women with elevated levels of sex hormones have 
more severe symptoms.5 Another hypothesis on the etiology of PMS proposes that 
emotional and physical symptoms may result from hormonal fluctuations during the 
menstrual cycle that alter brain neurotransmitter or neuropeptide function.6,7  In 
particular, some studies have observed luteal phase abnormalities in serotonin function in 
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women with PMS and a more severe form of PMS, premenstrual dysphoric disorder 
(PMDD), compared to symptom free controls.  Serotonin levels may be related to 
menstrual symptoms including depression, irritability, anger, and increased cravings for 
carbohydrates.6 Dietary intake of chocolate, alcohol, sugary drinks, and vitamin B6 have 
also been examined for their potential role in PMS, but results are inconclusive.7 Genetic 
predisposition to specific symptoms has been suggested by studies examining symptom 
occurrence in mother-daughter and twin relationships.5   
 The diagnostic definition for PMS established by the American College of 
Obstetricians and Gynecologists (ACOG), states that symptoms must be present in the 5 
days before a woman’s period for at least three menstrual cycles in a row and end within 
4 days after her period starts.1 Symptoms must interfere with normal life activities and 
may cause impairments in work performance, family and social activities, and sexual 
relationships.8 In contrast, the World Health Organization definition does not include 
timing, but only states that one symptom be present regardless of severity.8  Because 
there are no universally accepted diagnostic criteria, it is difficult to determine accurate 
prevalence rates and the impact of symptoms.   
 Recreational physical activity has been recommended as a method of reducing 
PMS occurrence and severity.  ACOG recommends aerobic exercise, in particular to 
reduce fatigue and depression associated with PMS.1 The U.S. Department of Health and 
Human Services recommends regular physical activity as a treatment for PMS9 and some 
sources suggest that aerobic exercise is an effective alternative to pharmaceutical 
treatments in easing PMS.10   Because the etiology of PMS is still unclear, identifying 
modifiable risk factors is important as PMS has such a high morbidity level and reduces 
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the quality of life for many women of reproductive age, and pharmaceutical treatments 
have limited efficacy and substantial side effects.7   
There are several plausible biological mechanisms by which physical activity 
could reduce PMS symptoms.  Aerobic physical activity may increase endorphin 
levels,6,11 decrease levels of estrogen12,13 and other steroid hormones,6 improve transport 
of oxygen in muscles,12 reduce cortisol levels,12 and improve psychological well-
being.11,14  All of these mechanisms support an inverse association of physical activity on 
PMS symptoms.  
Although physical activity has a multitude of health benefits, its association with 
reducing PMS occurrence and symptom severity is not well documented.  Previous 
observational studies examining this relationship have had inconsistent findings, with 
some studies suggesting a protective effect,11,14-20 one showing no association21 and two 
studies finding an increased risk of PMS symptoms among exercising women.22,23  One 
trial compared physical activity regimens for sedentary and active women;20 however, to 
our knowledge, no randomized control trials have included a non-exercising control 
group.6  Additionally, several of these studies had sample sizes of fewer than 100 total 
subjects.15-17,19  To our knowledge, only one study22 of physical activity and PMS 
adjusted for body mass index (BMI), a factor that likely also affects menstrual symptoms.  
One study examining obesity and PMS found that the prevalence of symptoms was 
significantly higher in obese women compared to underweight women (OR=2.9, 95% CI: 
1.1-7.5).24  Failure to control for BMI may thus lead to confounding due to the underlying 
relationship between physical activity and BMI.   
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Given that PMS etiology is still unclear and there is a need for knowledge of 
modifiable risk factors, it is important to determine if physical activity may reduce the 
risk of PMS.  Therefore, we investigated the relationship between physical activity and 
PMS using data from the University of Massachusetts (UMass) Vitamin D Study, a cross-
sectional study of 186 college-aged women.  
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CHAPTER II 
 
PHYSIOLOGY OF PHYSICAL ACTIVITY AND PREMENSTRUAL SYNDROME 
 
PMS occurs during the late luteal phase of the menstrual cycle.  On average, one 
menstrual cycle lasts 25-36 days beginning with the first day of menstruation.  This first 
phase of the cycle is known as the follicular phase and occurs on the first day of menses 
when estrogen and progesterone levels decrease at the end of the previous cycle.  
Following the follicular phase, the ovulatory phase of the cycle begins approximately on 
day 13 or 14 with a surge in luteinizing hormone that stimulates the release of an egg 
(ovulation).  The luteal phase begins after ovulation, and usually lasts approximately 14 
days, unless fertilization has occurred 25.  PMS occurs during the luteal phase of the 
cycle, most often with one week before menses.   
There are several biological mechanisms by which physical activity may reduce 
the occurrence of PMS.  These include an increase in endorphin levels,6,11 a stabilization 
of hormone levels and their effect on the hypothalamic-pituitary axes,6,12,13 improvements 
to oxygen in muscles,12 and an overall improvement to psychological well-being.11,14 
Endorphin levels in the body are the highest during the late follicular phase of the 
cycle and tend to decrease during the late luteal and menstrual phases.6,12  Low endorphin 
levels may contribute to PMS by decreasing a general overall feeling of wellbeing and 
leading to depression and other low emotional states.6 Physical activity has been shown 
to increase beta-endorphin levels, which improves mood and thus could reduce emotional 
symptoms.6,11   
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Physical activity may also improve PMS symptoms by impacting circulating 
hormone levels acting on the hypothalamic-pituitary-adrenal (HPA) axis.  The HPA axis 
is a part of the neuroendocrine system and is involved in regulating many body processes 
including digestion, the immune system, mood and emotions, sexuality, energy storage 
and expenditure, and stress reduction.26,27  A study by Roca and colleagues (2003) found 
that women with PMS did not have a normal increase in HPA axis response following a 
treadmill stress test conducted during the luteal phase compared to control women, and 
that menstrual cycle related variation in HPA axis function was affected by both 
progesterone and estrogen levels.28  These findings suggest that women with PMS have a 
decrease in HPA axis response during the symptomatic period, which could contribute to 
physical and emotional symptoms.28    
Physical activity may also impact the HPA axis by reducing cortisol levels 
through a modification to psychological or behavioral reaction to stress.  One study found 
that women with daily stress and suffering from PMS had higher levels of cortisol than 
control subjects,29 while a second study found that women who experienced more stress 
on a day-to-day basis (and thus had higher cortisol levels) had more frequent and severe 
PMS.30   
Other studies have found that physical activity may affect the hypothalamic-
pituitary-gonadal (HPG) axis causing a decrease to estrogen and progesterone levels, 
resulting in fewer menstrual symptoms.6 If physical activity decreases estrogen levels, 
this may also impact some of the major neurotransmitters that regulate mood and 
behavior, such as serotonin and Gamma Amino Butyric acid (GABA) that are affected by 
fluctuating estrogen levels during the luteal phase.5   
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Cramping, a common symptom of PMS, is caused by elevated tonic activity of 
the myometrium (uterine smooth muscle), which is stimulated by the sympathetic 
nervous system.  If pain results from hypoxia of the uterine muscle, vasoconstriction 
caused by stress (due to the enhanced sympathetic activity that results from 
environmental stress) would cause more pain, while physical activity could possibly 
alleviate this symptom.12   
Physical activity has also been shown to affect a women’s psychological outlook 
by improving self-esteem and providing a distraction from other thoughts, which could 
provide relief from emotional symptoms associated with PMS.11,14  Increased physical 
activity has been found to reduce tension, anger, depression, and low self-esteem, all of 
which are symptoms of PMS.12  Physical activity may also improve the functioning of the 
immune system, increasing the body’s resistance to stress.14   
In summary, there is biological evidence in support of an association between 
physical activity and reduction of PMS symptoms through a variety of physiological 
mechanisms.  These include increases to endorphin levels, helping to maintain the proper 
HPA axis response, decreases to sex steroids levels by impacting the HPG axis, reducing 
hypoxia of the uterine muscle, and improving emotional and psychological states of 
mind. 
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CHAPTER III 
 
 
EPIDEMIOLOGY OF PHYSICAL ACTIVITY AND PREMENSTRUAL SYNDROME 
 
 There have been a number of epidemiological studies examining the relationship 
between physical activity and PMS.  A majority of these studies have found a protective 
effect.11,14-19  However, one study showed no association21 and two studies found an 
increased risk of PMS symptoms among women who exercised regularly.22,23 All of these 
studies were observational except for one nonrandomized intervention study comparing 
physical activity regimens for sedentary and active women.20  No randomized control 
trials that have included a non-exercising control group have been published.6  
Additionally, some of these studies had sample sizes of fewer than 100 women.15-17,19  
Due to the cross-sectional design of most of these studies,11,14,16-18,22,23 temporality bias 
makes it difficult to determine if exercising is etiologically related in the development of 
PMS, or if those with PMS exercised more or less than those without PMS.  
 Rasheed and colleagues (2003)23 examined the relationship between several 
possible risk factors, including physical activity, and PMS among college-aged women in 
Saudi Arabia.  They conducted a cross-sectional study with 488 women enrolled in 
nursing, medical laboratory technology and respiratory therapy educational programs 
who were between the ages of 17 and 27.  They collected information on risk factors 
through a self-administered questionnaire that asked about level of physical activity 
(none, daily housework of at least 2 hours, three weekly sessions of walking or 
aerobic/rhythmic exercises for at least 20 minutes, or participation in sports).  Women 
were also asked to report whether they had experienced any of 14 menstrual symptoms 
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during the last 6 months for 3 or more cycles within one week prior to the onset of 
menstruation.  Scores were assigned based on whether the symptom was described as 
mild (score=1; daily activities not affected and no medication taken), moderate (score=2; 
daily activities not affected but medication was taken), or severe (score=3; daily activities 
were affected despite medication).  Each woman was assigned a PMS symptom score 
from 0 (no symptoms) to 42 (maximum of 14 severe symptoms).  The authors found that 
96.6% of women in the study reported experiencing at least one menstrual symptom 
within the last 6 months.  Findings from a univariate analysis show that physically active 
women were more likely to have high PMS symptom scores compared to sedentary 
women, with 45.3% of physically active women having high ranged scores (10-33) 
compared to 30.6% of sedentary women (P<0.01).  It is unclear how the women were 
divided into physically active and sedentary groups, as there was no description of this 
categorization, and no further statistical analysis on the difference between the two 
groups was conducted.   Due to the cross-sectional design, temporal bias is an issue for 
this study, as it is unclear whether women experienced PMS and started or stopped 
exercising to alleviate symptoms, or exercised regularly and never experienced PMS.  
The total score for PMS symptoms was also arbitrarily categorized into three levels (0, 1-
9, ≥10) without any explanation for this process.  Because information was collected by 
questionnaire, misclassification of outcome is a limitation of the study as the question on 
PMS asked about symptoms during the last 6 months, which can be difficult to remember 
at one point in time.     
 A longitudinal study, conducted by Choi et al.14 examined the relationship 
between physical activity and changes in emotional and physical symptoms during the 
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menstrual phase to determine if symptoms worsened during the luteal premenstrual 
phase.  The study included 143 women ages 15-48 from the United Kingdom who were 
categorized based on how often they said they exercised each week.  Women were 
classified as competitive athletes (those training for competitive or public events), high 
exercisers (3 or more times per week), low exercisers (less than 3 times per week), or 
sedentary.  Women were asked to complete a mood questionnaire every night for one 
month beginning on the first day of their menstrual cycle and ending on the first day of 
their following period, with the premenstrual phase being defined as the 5 days prior to 
menstruation.  The questionnaire included 42 items describing moods and physical states. 
The authors found that during the premenstrual phase, high exercisers had the lowest 
mean score for negative affect characteristics including irritability and fatigue, and the 
lowest mean score for physical symptoms such as cramps and dizziness.  Sedentary 
women, low exercisers, and competitive exercisers had higher mean scores than the high 
exercisers in all of these groups; however, there was no linear relationship between 
physical activity and improved PMS symptoms.  One potential limitation of this is study 
is the reproducibility of symptom scores over time.  Although symptoms were examined 
within the 5 days before menstruation, questionnaires were only administered for one 
month, and therefore it is difficult to determine whether these symptoms occurred for the 
women in every menstrual cycle or only during that month.  Because the women knew 
that this study was being conducted to examine physical activity and the menstrual cycle, 
they may have been more aware of symptoms while filling out the questionnaire than 
during an unobserved cycle.  This is likely not to differ by physical activity level.    
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 In one of the first and most cited studies examining physical activity and PMS, 
Timonen and Procopé18 recruited 748 women from the Helsinki University in Finland 
into a cross-sectional study.  They collected data on physical activity and PMS with a 60-
question survey.  The authors compared women who were studying physical education 
(n=136) and those in other programs (n=612) with the assumption that those studying 
physical education exercised more frequently than those studying other fields.  They 
found that the percentage of women experiencing premenstrual and menstrual low back 
pain, premenstrual and menstrual pelvic pain, premenstrual and menstrual headache, 
premenstrual nervousness, irritability, anxiety, depression and fatigue were all 
significantly higher (P<0.05) in women studying in other programs compared to those 
studying at the Institute of Physical Education.  These findings, however, are based on 
the assumption that physical education students were more active, though this assumption 
was not validated.  Other researchers in the field have criticized this study because 54% 
of the population was under 22, an age group where anovulation occurs quite frequently 
(9-70% of cycles); because only a single cycle was assessed, it was unclear whether 
menstrual symptoms were assessed during an ovulatory cycle when symptoms are more 
likely to occur.13 Possible confounding by BMI is also an issue.     
 In summary, previous studies of physical activity and PMS have reported 
inconsistent results, with most finding physical activity inversely associated with 
menstrual symptom severity. However, limitations of several of the studies that found 
this protective effect include recall bias, using different definitions of PMS, and likely 
misclassification of physical activity levels.  Other studies have had small sample sizes, 
and thus had limited power to assess this relationship. To our knowledge, only one study 
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in this review adjusted for BMI.22 Our study will use validated physical activity and PMS 
assessments, and evaluate many covariates associated with PMS, including BMI.
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CHAPTER IV 
 
 
SUMMARY 
 
 Up to 85% of women who menstruate experience at least one menstrual symptom 
two weeks before menstruation begins.1 The ACOG defines PMS as a disorder in which 
symptoms are present in the 5 days before a woman’s period begins for at least three 
menstrual cycles in a row and that end within 4 days after her period starts, which 
substantially interfere with normal life activities.1 Although many prominent 
organizations, including the U.S. Department of Health and Human Services,9 
recommend physical activity for easing PMS symptoms, there is little conclusive 
evidence of a benefit of physical activity.  Results of observational studies are 
inconsistent and there are clear opportunities for bias and misclassification in studies 
examining these two factors.  Because the etiology of PMS remains unclear and the 
effectiveness of pharmaceutical treatments is limited, knowledge of modifiable risk 
factors is important to help alleviate symptoms in women who suffer each cycle.   
 Physical activity may reduce PMS symptoms through a number of physiological 
mechanisms.  These mechanisms include increasing endorphin levels, regulating 
hormone levels, increasing oxygen supply to the muscles, reducing cortisol levels, and 
promoting a less stressful and better outlook on life.   
 Several epidemiological studies suggest a protective effect of physical activity on 
PMS symptoms.  Although these studies had several limitations including temporality 
bias and misclassifications, they provide some evidence that physical activity may 
minimize symptom occurrence.   
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 Using a cross-sectional design, we examined the association between physical 
activity and prevalent PMS using data from the UMass Vitamin D Study.  Recreational 
physical activity and prevalent PMS was assessed through validated questionnaires in a 
group of menstruating college-aged women.  We controlled for BMI and several other 
possible confounding factors.  
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CHAPTER V 
 
 
HYPOTHESES AND SPECIFIC AIMS 
 
 
Using a cross-sectional design, we evaluated the relationship between recreational 
physical activity and prevalent PMS symptoms among college-aged women.  The 
following aims were addressed: 
 
Specific Aim 1: To assess the association between physical activity and risk of 
PMS.  
Hypothesis 1:  College-aged women who participate in recreational physical 
activity will be less likely to experience PMS than women who do not participate 
in recreational physical activity.   
 
Specific Aim 2: To examine the effect BMI has on the relationship between 
physical activity and PMS and menstrual symptoms.  
Hypothesis 2: Results adjusted for BMI will be stronger than those unadjusted for 
BMI. 
 
Specific Aim 3: To examine if physical activity is associated with the occurrence 
of specific menstrual symptoms.    
Hypothesis 3:  Women who participate in more recreational physical activity will 
be less likely to experience moderate-severe symptoms compared to women who 
participate in less physical activity.   
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CHAPTER VI 
 
 
METHODS 
 
 
Study Design and Population 
 This study examined the relationship between physical activity and 
PMS/menstrual symptoms using data from the University of Massachusetts (UMass) 
Vitamin D Study, a cross-sectional study that was conducted at UMass in Amherst, 
Massachusetts between March 2006 and June 2008.  The primary purpose of the UMass 
Vitamin D Study was to assess factors associated with vitamin D status in young women.  
A secondary aim of the study was to assess dietary, lifestyle, and biochemical factors 
associated with PMS.   
 Participants were women aged 18-30.  Women were invited to participate in the 
study through fliers posted on the UMass campus. Women of all ethnicities were 
welcome to participate.  Women were ineligible to participate if they: were pregnant or 
not currently menstruating; were experiencing untreated depression; reported high blood 
pressure or elevated cholesterol, kidney or liver disease, bone disease such as 
osteomalacia, digestive disorders, rheumatologic disease, multiple sclerosis, thyroid 
disease, hyperparathyroidism, cancer, type 1 or type 2 diabetes, or polycystic ovaries; or 
were currently using corticosteroids (such as prednisone, anabolic steroids, 
anticonvulsants, Tagmet, Cimetidine, or propranolol).  Participants were asked to 
complete food-frequency and demographic questionnaires, provide a fasting venous 
blood sample (45 mL) drawn in the early morning during the late luteal phase of the 
menstrual cycle, and provide a urine sample via a clean catch. The following 
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measurements were also taken: fasting blood sugar via glucometer; hemoglobin via 
hemoglobinometer; blood pressure; waist circumference; height; weight; and a dual 
energy X-ray absorptiometry (DEXA) bone scan to determine body composition and 
bone mineral density.  Study participation required 1.5 to 2 hours of time to complete the 
measurements, and participants were given $10 compensation as well as the results from 
the DEXA scan, blood glucose test, and a nutrient analysis of their diet.  A total of 186 
women participated in the study. 
 
Exposure Assessment 
 Physical activity was assessed through a self-reported questionnaire.  Participants 
were asked to report the average time they spent each week over the past month engaging 
in specific activities including walking, hiking, jogging, running, bicycling, aerobics or 
dancing, tennis or other racket sports, swimming, yoga or Pilates, and weight training.  
Response options ranged from zero minutes to 11+ hours per week.  Questionnaire 
responses were used to calculate metabolic equivalent task (MET) hours per week, which 
considers the duration and intensity of physical activity. METs are a measure of energy 
expenditure equal to the ratio of metabolic rate at work to resting metabolic rate, and vary 
by intensity of a specific type of physical activity.  One MET is defined as the energy 
expended while sitting quietly.31  We examined physical activity in both continuous 
METs per week and in tertiles of METs per week.   
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Validity of Exposure Assessment 
The questions on physical activity were based on a previous questionnaire used in 
the Nurses’ Health Study II (NHSII) and have been previously validated in a population 
of 147 young women.32 Test-retest correlation for the questionnaires administered 2-
years apart were 0.59.  Correlation between activity level reported in 7-day activity 
diaries and that reported on the questionnaire was 0.62.  The types of physical activity 
included on the questionnaire were the most common types of physical activity reported 
by women in the University of Pennsylvania Alumni Health Study.32   
 
Outcome Assessment 
 Information on menstrual symptoms was collected through self-reported 
questionnaire.  Participants were asked to provide information on 26 different symptoms 
by responding to the following statement: “For each symptom listed below, please 
indicate whether you experience it most months of the year, for at least several days 
before your menstrual period begins.” Participants were asked not to include symptoms 
that they experienced throughout their entire menstrual cycle, or symptoms that start only 
when their period starts.  Participants were asked to indicate the usual severity of each 
symptom as mild, moderate, severe, or “not at all”.   Participants were also asked to 
indicate whether their overall severity of symptoms was “minimal” (no effect on normal 
activities); “mild” (noticeable, but not troublesome); “moderate” (interferes with normal 
activities); or “severe” (intolerable, prevents normal activities).   
In addition, women were asked to report the number of days before their period 
when symptoms usually began, as well as the number of days the symptoms lasted after 
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their period began.  Women were then asked to report whether they experienced 
relationship discord with family or a partner; relationship discord with friends or 
coworkers; poor work performance or attendance; social isolation; and suicidal thoughts, 
and to indicate the severity of each of these problems (mild, moderate, or severe).  
Finally, women were also asked to report whether they had ever been clinically 
diagnosed with PMS.   
 Responses to the menstrual symptom questionnaire were used to identify women 
meeting clinical criteria for PMS based on those developed by Mortola et al.33 A woman 
was considered a case if she reported: 1) at least one physical and one affective menstrual 
symptom; 2) overall symptom severity of “moderate” or “severe”, impact of symptoms 
on life activities and relationships of “moderate” or “severe”, or one or more individual 
symptoms rated as “severe”; 3) symptoms beginning within 14 days of the start of 
menses; 4) symptoms ending within 4 days of the start of menses; and 5) symptoms are 
absent in the week after menses.  The menstrual symptom questionnaire was also used to 
identify women with few or no menstrual symptoms to serve as controls. Controls were 
women who reported: 1) overall symptom severity of “none” or “mild” for all individual 
symptoms; 2) overall symptom severity of “none”, “minimal” or “mild”; 3) impact of 
symptoms on life activities and relationships of “not a problem” or “mild” for all items; 
and 4) no previous clinical diagnosis of PMS.   
 
Validity of Outcome Assessment 
 The questionnaire used for this study to assess PMS is based on the Calendar of 
Premenstrual Experiences designed by Mortola et al.33 and similar to that used in the 
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NHSII.34 A validation study on the questionnaire used in the NHSII showed that 
menstrual symptom timing, occurrence, and severity in PMS cases identified with those 
criteria were similar for women who reported that the “gold standard” of prospective 
symptom charting had been used in making their diagnosis.34   
 
Covariate Assessment 
 Covariate information was collected through a self-reported questionnaire 
measuring factors including age, age at first menstruation, current oral contraceptive use, 
smoking status, marijuana use, hours of sleep per weeknight, history of reproductive tract 
infections, and history of depression or bipolar disorder.  Results from the food frequency 
questionnaire were used to determine intake of vitamin D and calcium from food sources 
as well as daily alcohol consumption. Body composition was measured by study staff 
through use of a DEXA scan. Height and weight were measured directly and used to 
calculate BMI (weight [kg]\height [m]2).   
 
Data Analysis Plan 
Specific Aim 1: To assess the association between physical activity and risk of PMS.  
 
Univariate Analysis 
We calculated the number and percent of subjects based on PMS status as well as 
by tertile of METs/week of physical activity.  We also calculated the distribution of 
physical activity in METs/week based on PMS status.   
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Bivariate Analysis 
 We cross-tabulated covariates with outcome and exposure variables to evaluate 
potential confounders.  We also cross-tabulated continuous covariates with PMS status in 
a separate analysis.  Cross-tabulations were evaluated using a chi-square test to determine 
if the observed distribution fit the expected distribution when the cell size was sufficient, 
and with Fisher’s Exact test if cell counts were small (<5).   
 
Multivariate Analysis 
 The relationship between physical activity and PMS was modeled using 
multivariable logistic regression.  Two analyses were conducted; the first examined 
physical activity categorized into tertiles of MET-hours/week, the second examined 
continuous physical activity in units of 10 MET-hours/week as the exposure.  We 
calculated odds ratios (ORs) and 95% confidence intervals (95% CI).   
 Confounders were evaluated by examining the physical activity/PMS relationship 
by running the model with each covariate separately.  Any covariate whose addition to 
the model changed the odds ratio by 10% or more was retained in the model as a 
confounder.   
 
Specific Aim 2: To examine the effect BMI has on the relationship between physical 
activity and PMS and menstrual symptoms.  
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Multivariate Analysis 
 Confounding by BMI and percent body fat were examined by evaluating the 
physical activity/PMS relationship in regression models with and without these variables 
and comparing odds ratios between the models.  Effect modification was assessed by 
stratifying our population by BMI (<22.5 vs. ≥ 22.5 kg/m2) and then calculating stratum 
specific odds ratios for the relationship between continuous BMI and PMS.  We then 
created a multiplicative interaction term (continuous physical activity*BMI strata) and 
included this term in the multivariable regression model along with terms for continuous 
physical activity and BMI.  The Wald P-value for the interaction terms was used to assess 
whether interaction was significant (P<0.05).   
 
Specific Aim 3: To examine if physical activity is associated with the occurrence of 
specific menstrual symptoms.    
 
Multivariate Analysis 
 The relationship between physical activity and PMS symptoms was modeled 
using multivariable logistic regression.  For this analysis, we evaluated continuous levels 
of physical activity, in 10 MET-hours/week. Symptoms were dichotomized into 
none/mild or moderate/severe, based on the previously identified criteria.  We included 
those covariates identified as confounders in the main analysis.   
 
The data analysis for this paper was performed using SAS software, Version 9.2 for 
Windows (SAS Institute Inc., Cary, NC, USA).  
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CHAPTER VII 
 
 
SIGNIFICANCE 
 
 
 Previously published studies on physical activity and PMS have reported 
inconsistent results.  Because physical activity is a potential modifiable risk factor for a 
condition that affects many women, additional research to evaluate this relationship is 
important.  Results from this study could help inform future research and randomized 
trials that examine exercise and PMS. The results could also be used to help modify 
current guidelines recommending exercise as a treatment for PMS and menstrual 
symptoms. 
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CHAPTER VIII 
 
 
HUMAN SUBJECT PROTECTION 
 
 
 The Vitamin D Study was approved by the Institutional Review Board at UMass 
Amherst in Amherst, Massachusetts. All participants were required to sign informed 
consent documents prior to their participation, the completion of questionnaires, or 
biologic sample collection.  Participants were provided specific information about 
confidentiality and told that they are allowed to withdraw from the study at any time.   
 All participant personal information, including questionnaires, biologic samples, 
and clinical measurements are kept in a secure location in the UMass Vitamin D Study 
office at the School of Public Health UMass Amherst. All participant names and ID’s are 
stored in locked filing cabinets separate from study data to maintain confidentiality.  
Questionnaires and all data are identified by ID numbers only.  All computerized 
documents are password protected.   
 There are no known risks to the study participants, except for the possibility of 
discomfort associated with having blood pressure taken, blood drawn, urine collected, 
undergoing studies of genetic factors, or undergoing a DEXA scan.  As mentioned 
earlier, the participant can withdraw at any time, also preventing any emotional distress 
that may occur.  Accidental breach of confidentiality is highly unlikely to occur, as 
security procedures are maintained for every document involved in the study.  There are 
no known benefits to the participants, except for receiving their $10 compensation as well 
as the results from the DEXA scan, blood glucose test, and a nutrient analysis of their 
diet.  Data are used for medical statistical purposes only.  
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CHAPTER IX 
 
 
PERMISSION TO ACCESS DATA 
 
I, Aimee Kroll, have been granted permission to use the data from the UMass Vitamin D 
study by the co-Principal Investigator of the Vitamin D Study, Elizabeth Bertone-
Johnson, for the purposes of this thesis.   
 
Signed:  
 
___________________________________ 
Elizabeth R. Bertone-Johnson, ScD  
 
 
 
 
___________________________________ 
Aimee Kroll 
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CHAPTER X 
 
 
RESULTS 
 
 
 Table 2 shows the distribution of PMS status by study participants for those that 
met either the case or control criteria.  About half (49%) of the total 186 participants met 
either one of these definitions, with 44 meeting case criteria and 46 meeting control 
criteria.  Table 3 shows the distribution of participants by physical activity tertile for all 
186 study participants. The ranges of MET values in our population was relatively large, 
with women in the highest tertile reporting at least 65 MET-hours per week. Table 4 
shows the distribution of PMS cases and controls by physical activity tertile.   
 Characteristics of PMS cases and controls are presented in Table 5.  A total of 4% 
of controls reported that they had ever smoked, compared to 30% of cases (P=0.001).  
For marijuana smoking, 17% of controls reported ever smoking marijuana compared to 
32% of cases (P=0.11).  Vitamin D status also differed between cases and controls, with 
64% of cases and 83% of controls reporting intake from food sources over 100 IU/day or 
more (P=0.04).  Intake of calcium from food sources had a similar pattern, with 58% of 
controls in the highest intake group (>1200 mg/day) and only 21% of cases (P=0.06).  
Age, age at first menses, BMI, alcohol consumption, hours of sleep per weeknight, 
current oral contraceptive use, history of reproductive tract infections, diagnosis of 
depression or bipolar disorder, and percent body fat did not differ significantly between 
cases and controls.  Cases and controls also had similar mean values for age, age at first 
menses, BMI, alcohol consumption, vitamin D intake, calcium intake, and percent body 
fat (Table 6).   
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 When examining the distribution of covariates by physical activity tertile (Table 
7), fewer women in the highest tertile were ever smokers or had their first menses before 
the age of 12 than in the lower two tertiles, though these differences were not significant. 
For example, 8% of women in the highest tertile were ever smokers compared to 17% in 
tertile 2 and 13% in tertile 1 (P=0.31). Current oral contraceptive use significantly 
differed between tertiles, with 28% of women in the highest tertile currently using oral 
contraceptives compared to 51% in tertile 2 and 39% in tertile 1 (P=0.03).  Women in the 
highest tertile of physical activity consumed greater amounts of calcium when compared 
to women in the lower two tertiles (>1200 mg/day: Tertile 3- 46%; Tertile 2- 24%; 
Tertile 1- 21%) (P=0.01). Distribution of age, BMI, alcohol consumption, hours of sleep 
per weeknight, marijuana use, history of reproductive tract infections, diagnosis of 
depression or bipolar disorder, vitamin D intake, and percent body fat were similar across 
all three tertiles.   
 In unadjusted analyses physical activity was not associated with PMS.  Women in 
tertile 2 had a non-significant 59% increased risk of PMS compared to women in tertile 1 
(95% CI: 0.59-4.33) and women in tertile 3 had a non-significant 53% increased risk of 
PMS compared to women in tertile 1 (95% CI: 0.53-4.34).  Results were similar after 
controlling for age and history of depression or bipolar disorder; the OR for women in 
tertile 2 versus tertile 1 was 1.62 (95% CI: 0.58-4.51) while the odds ratio for tertile 3 
versus tertile 1 was 1.67 (95% CI: 0.57-4.92). When examining the association between 
continuous level of physical activity (per 10 MET-hours/week) and PMS, the 
multivariable odds ratio was 1.03 (95% CI: 0.94-1.14), where every 10 MET-hour/week 
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increase in physical activity corresponds to a non-significant 3% increase in PMS (Table 
8).   
 Secondly, we were interested in examining the effect of adjustment for BMI and 
percent body fat on multivariable odds ratios.  We included BMI as a measure of body 
mass, and included percent body fat from the DEXA scan as a measure of lean body 
mass.  Table 9 shows four multivariable models: 1) not including BMI or percent body 
fat; 2) including only BMI; 3) including only percent body fat; and 4) including both 
BMI and percent body fat.  There was no significant change in the odds ratios for 
physical activity among the four models, indicating that neither BMI nor percent body fat 
confounded the relationship between physical activity and PMS.  When examining the 
relation between each 10 MET-hour/week change in physical activity and PMS risk, odds 
ratios and 95% confidence intervals were also similar for all four multivariable models 
(Table 9).   
 We also examined if BMI modified the relationship between physical activity and 
PMS.  We found no significant difference in the relationship between continuous level of 
physical activity and PMS between strata.  The odds ratio for women in the lower BMI 
category (<22.5 kg/m2) was 1.06 (95% CI: 0.90-1.26) while the odds ratio in the higher 
BMI category (≥22.5 kg/m2) was 1.01 (95% CI: 0.89-1.15) (Table 10).  The P-value for 
interaction was 0.68. 
 We then examined the association between each 10 MET-hour/week change in 
physical activity and the occurrence of 26 specific menstrual symptoms, with our 
outcome being moderate-severe severity versus none-mild severity for each symptom 
(Table 11).  All models were adjusted for age and history of depression or bipolar 
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disorder.  Every 10 MET-hour/week increase in physical activity was associated with a 
13% lower risk of headache (OR=0.87, 95% CI: 0.74-1.01); a 5% increased risk of food 
cravings, changes in appetite, irritability and emotional hypersensitivity (OR=1.05, 95% 
CI: 0.99-1.11); and a 10% increase in risk of forgetfulness (OR=1.10, 95% CI: 1.00-
1.21).   
 In additional analyses, we examined the association between meeting 
recommended physical activity guidelines and risk of PMS.  Current guidelines 
recommend at least 30 minutes of moderate intensity physical activity on most days of 
the week, corresponding to 10 MET-hours/week (0.5 hr * 4 METs * 5 days = 10 MET-
hrs/week).35 We found no evidence in decrease of risk in women who met this 
recommended criteria compared to those who did not meet the recommended physical 
activity criteria, either in unadjusted models or after adjusting for age and diagnosis of 
depression or bipolar disorder (multivariable OR=1.11, 95% CI: 0.31-3.99).  
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CHAPTER XI 
 
 
DISCUSSION 
 
 
 In this cross-sectional study of 186 premenopausal women, we found no 
association of physical activity with PMS or menstrual symptoms.  Results from age and 
history of depression or bipolar disorder adjusted models were also null.  Physical 
activity modestly but non-significantly increased risk of moderate to severe food 
cravings, changes in appetite, irritability, emotional hypersensitivity and forgetfulness 
and reduced the risk of headache.   
 Unlike prior studies,11,14-18,20 we found no significant decrease in risk of PMS or 
menstrual symptoms in women who were more physically active compared to women 
who were not physically active or who were less physically active.  We observed no 
substantial association even after adjusting for BMI and percent body fat, which gave us 
a representation of lean body mass for each participant.  However, our sample size was 
small and confidence intervals were wide, possible explaining our lack of significant 
findings.  Given our small sample size, our power for the study was relatively low, with 
80% power to detect an odds ratio of 2.7.  It is possible that with a larger sample size, we 
may have had more power to detect a modest association.  The range of physical activity 
in our study population may have also affected our results.  Because the physical activity 
range was so high, we did not have enough power to examine substantially low activity 
women compared to high activity women, another possible explanation for our null 
findings.   
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Two previous studies22,23 found an increased risk of PMS for physically active 
versus inactive women.  Deuster et al. found that 10% of highly active women 
experienced PMS compared to 4.7% of inactive women, and inactive women had a 
significant 60% reduction in PMS symptoms (95% CI: 0.2-0.7) after adjustment for race, 
age, age at menarche, smoking, BMI, alcoholic drinks, and nutritional habits among other 
factors.22  Rasheed et al. showed that 45.3% of physically active women had high 
premenstrual symptom scores compared to 30.6% of sedentary women based on a self-
reported questionnaire on symptom severity.23  Both of these studies were similar to ours 
by cross-sectional design and questionnaires that determined physical activity status and 
PMS and menstrual symptom severity. 
It is possible that our results were affected by bias. Nondifferential 
misclassification of exposure may arise if physical activity is measured inaccurately, 
independent of PMS assessment.  Because physical activity was measured through a self-
reported questionnaire, it is possible that women under or over reported their physical 
activity, did not report on specific activities, or participate more in occupational or 
lifestyle physical activity compared to recreational activity.  Any nondifferential 
misclassification of exposure that occurred will bias the results toward the null, therefore 
making any association weaker.  However, we used a questionnaire that has been 
previously validated through comparisons with physical activity diaries, making it 
unlikely that any nondifferential misclassification of exposure would bias our results 
substantially.32 
 Nondifferential misclassification of outcome could occur if PMS and menstrual 
symptoms were measured inaccurately.  Because menstrual symptoms were measured 
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with a self-reported questionnaire, it is possible that some nondifferential 
misclassification of outcome could occur, independent of physical activity assessment.  
Women may under or over report symptoms or severity of symptoms, not report on 
specific symptoms, or may have been unclear about the definition of symptom severity.  
However, we asked women about their usual menstrual symptoms, making it easier to 
recall specific symptoms and their severity if they occur each month, opposed to 
questions asking about a specific time period.  Any nondifferential misclassification of 
outcome that occurred would have biased our results closer to the null. 
 Selection bias, in the form of non-comparable selection, may have occurred if 
women who experience PMS and are physically active were more motivated to 
participate in the study than other women, or if women who do not experience PMS 
symptoms and are not physically active were less motivated to participate.  If women 
who have severe PMS and participate in high amounts of physical activity were more 
likely to join the study because they wanted to know what causes their symptoms, our 
results would be overestimated if exercise truly reduces PMS.  However, because the 
study was conducted primarily to look at vitamin D status, women agreeing to participate 
in the study were unlikely to make a connection between questions asking about PMS 
and physical activity habits.   
 Information bias may occur in the form of recall bias if women who experience 
PMS and menstrual symptoms are more motivated to accurately report their physical 
activity habits compared to women who do not experience PMS.  This is unlikely in our 
study, because as noted earlier the study’s primary objective was to assess vitamin D 
status. It is unlikely that a participant could know that an association between physical 
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activity and PMS would be examined as the questions on the questionnaire were in 
separate unrelated sections.  However, because physical activity is often recommended to 
help alleviate PMS, a woman may nonetheless make this connection.  Because the 
questions on PMS come before the questions on physical activity in our study 
questionnaire, a woman who answered the questions on PMS and felt like it was an 
important issue based on her responses may be more likely to recall her physical activity 
differently compared to a woman who did not notice a trend with her questions on the 
PMS section.  In this situation, a woman may underreport her physical activity if she 
believes she does not participate in enough physical activity to help ease menstrual 
symptoms and PMS.  If this type of information bias did occur in our study, our results 
would be underestimated because she would be considered unexposed and experiencing 
PMS.  
 In a cross-sectional study, it is often difficult to determine whether the exposure 
preceded the outcome or vice versa.  In our study, we are unable to know if women 
experiencing PMS started exercising to help alleviate symptoms, if women who have 
been exercising regularly do not experience PMS symptoms because of the physical 
activity, or if women who experience PMS do not participate in physical activity because 
their symptoms are so severe they do not feel well enough to exercise.  Temporality bias 
in our study will bias our results depending on the scenario.   If exercise is protective then 
we assume that cases exercise less than controls. If a case starts exercising more to treat 
her symptoms, she thus increases her exposure level and makes the overall level in cases 
more similar to controls, therefore biasing our results toward the null.  In another 
example, if a case who has been exercising stops exercising because her symptoms are 
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severe, she thus decreases her exercise level and makes the overall level of activity in the 
cases even lower and more different from controls, therefore biasing our results away 
from null, making exercise look more protective.  
 Survival bias in a cross-sectional study can occur if people who are exposed are 
more likely to die due to the outcome.  Because there is no risk of mortality from physical 
activity or PMS, this type of bias is not a concern in our study.   
 It is possible that there was some residual confounding that affected our results in 
either direction depending on the type of confounding variable.  An example of a 
confounder that we did not collect data on is stress.  Stress has been shown to be 
associated with a greater risk of PMS.22  Confounding by stress could exist in two 
separate scenarios.  If stress caused a woman to participate in more physical activity as a 
means of alleviating stress, and stress was the true cause of PMS, less PMS would be 
attributed to her physical activity, not the reduction of her stress, therefore biasing an 
inverse association to the null.  Likewise, if a woman who experienced stress exercised 
less because she felt like she had too many other things to do, her PMS would bias an 
inverse association away from the null.  Although stress may play a role in our findings, 
we believe that women who are under a great deal of stress probably would not take the 
time to participate in this study, therefore making this situation unlikely to affect our 
results substantially.  
 Another potential limitation of our study is using multiple comparisons to 
examine the relationship between physical activity and specific menstrual symptoms.  We 
did not adjust for multiple comparisons in our analysis.  However, doing so would not 
have had much affect on our results as they were null.   
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The results of our study could be applicable to premenopausal women, as the 
biological mechanisms that relate physical activity to PMS likely do not vary by race or 
ethnic origin.   
In conclusion, we found no association with physical activity and the occurrence 
of PMS and menstrual symptoms.  It is possible that our cross-sectional design led to 
several biases and that the temporal relationship between physical activity and PMS 
could not be examined in a cross-sectional study.  The relationship between physical 
activity and PMS remains unclear.   Further research in the form of prospective studies 
and randomized trials, to minimize biases associated with cross-sectional studies, should 
be conducted in this area before concluding that physical activity and PMS are 
associated. 
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TABLES 
 
Table 1: Classification of Study Variables 
Name Description Type  Variable Group 
bloat PMS symptom: Abdominal bloating 
• 1 = Not at all 
• 2 = Mild 
• 3 = Moderate 
• 4 = Severe 
Categorical Outcome 
tender  PMS symptom: Breast tenderness 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
dizzy PMS symptom: Dizziness 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
head  PMS symptom: Headache 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
hot  PMS symptom: Hot flashes 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
naus  PMS symptom: Nausea 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
swell  PMS symptom: Swelling in extremities 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
acne  PMS symptom: Acne 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
const  PMS symptom: Diarrhea/constipation 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
crave  PMS symptom: Food cravings 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
palp PMS symptom: Palpitations  
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
anx  PMS symptom: Anxiety/nervousness 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
appet PMS symptom: Increased/decreased appetite 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
irrit  PMS symptom: Irritability 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
hyper  PMS symptom: Emotional hypersensitivity 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
fatig  PMS symptom: Fatigue 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
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mood  PMS symptom: Mood swings 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
cry  PMS symptom: Tendency to cry easily 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
insom  PMS symptom: Insomnia  
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
angry  PMS symptom: Angry outbursts 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
alone  PMS symptom: Desire to be alone 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
depres PMS symptom: Depression 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
confus PMS symptom: Confusion 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
forget  PMS symptom: Forgetfulness 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
cramp  PMS symptom: Abdominal cramping 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
back  PMS symptom: Lower back pain 
• Categories as for variable “bloat,” 
above 
Categorical Outcome 
pms PMS symptom: Lower back pain 
• 1 = Case 
• 0 = Control 
Categorical  Outcome 
pa_tot  Recreational activity: MET hours/week Continuous Exposure 
patert Recreational physical activity: Tertiles Categorical Exposure 
METS10 Recreational activity: 10 MET hours/week Continuous Exposure 
age_m Age menstrual periods began 
• 1 = ≤ 9 years old 
• 2 = 10 years old 
• 3 = 11 years old 
• 4 = 12 years old 
• 5 = 13 years old 
• 6 = 14 years old 
• 7 = 15 years old 
• 8 = 16 years old 
• 9 = ≥ 17 years old 
Categorical Covariate 
 
curr_oc Currently using OCs 
• 1 = Yes 
• 0 = No  
• 99 = blank 
Categorical Covariate 
cur_smk Currently smoke 
• 1 = Yes 
• 0 = No 
Categorical Covariate 
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smk_mar Do you smoke marijuana 
• 1 = Yes 
• 0 = No 
Categorical Covariate 
alco Alcohol consumption in grams per day Continuous Covariate 
ill  Ever had any of the following clinician-
diagnosed illnesses (mark all that apply) 
• 1 = Lactose intolerance 
• 2 = Depression (unipolar depression) 
• 3 = Bipolar disorder (manic 
depressive illness) 
• 4 = Endometriosis 
• 5 = Uterine fibroids 
• 6 = None of the above 
Categorical Covariate 
wd_slp On an average weekday, how many hours do 
you sleep per night? 
• 1 = ≤3 hours 
• 2 = 4-5 hours 
• 3 = 6-7 hours 
• 4 = 8-9 hours 
• 5 = ≥10 hours 
Categorical Covariate 
rti  In the past 6 months, have you been treated by 
a healthcare provider/ treated yourself for any 
of the following reproductive tract infections 
(mark all that apply) 
• 1 = Bacterial vaginosis (BV) 
• 2 = Yeast 
• 3 = Chlamydia 
• 4 = Gonorrhea 
• 5 = Trichomoniasis 
• 6 = Syphilis 
• 7 = Genital warts 
• 8 = Genital herpes 
• 9 = Not sure 
• 10 = None of the above 
• 99 = missing 
Categorical Covariate 
vitd_wo Vitamin D intake per day (IU) from food 
sources 
Continuous Covariate 
calc_wo Calcium intake per day (mg) from food 
sources 
Continuous  Covariate 
Bodyfat % Body fat from DEXA Continuous Covariate 
Bmi  BMI Calculated Continuous Covariate 
Agequart Age quartiles: 
• 1 = 18-18.99  
• 2 = 19-20.99  
• 3 = 21-22.99  
• 4  = ≥23  
Categorical Covariate 
Men_age Age at first menstruation: 
• 1 = ≤12  
• 2 = >12  
Categorical Covariate 
bmicat_a BMI categories:  
• 1 = 16.5-24.9  
• 2 = ≥25  
Categorical Covariate 
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Alcocat Alcohol consumption: 
• 1 = 0  
• 2 = 0.88-3.07  
• 3 = 3.08-7.92 
• 4 = 7.93-69.78  
Categorical Covariate 
Wd_slp Weekday sleep (hours): 
• 1 = 4-7  
• 2 = ≥8  
Categorical Covariate 
rticat History of reproductive tract infection: 
• 1 = Yes  
• 0 = No  
• 2 = Missing  
Categorical Covariate 
Illcat Diagnosis of depression or bipolar disorder: 
• 1 = Yes 
• 0 = No 
Categorical Covariate 
Vitdcat Vitamin D intake: 
• 1 = <100 
• 2 = ≥100 
Categorical Covariate 
Calccat Calcium intake: 
• 1 = 0-599 
• 2 = 600-1200 
• 3 = >1200 
Categorical Covariate 
Bodyfatq Body fat quartiles: 
• 1 = 14.5-26.1 
• 2 = 26.2-31.6 
• 3 = 31.7-37.3 
• 4 = 37.4-50.1 
Categorical Covariate 
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Table 2: Distribution of PMS Status among Study Participants (n=186) 
 N % 
PMS Case 44 24 
PMS Control 46 25 
Total 90 49 
 
 
Table 3: Distribution of Physical Activity Status among Study Participants (n=186) 
 N % Median Range 
Physical activity tertile 1 62 33 16.1 0-23.9 
Physical activity tertile 2 63 34 42.8 24.1-65.1 
Physical activity tertile 3 61 33 100.3 65.4-374.2 
*Median and range in MET-hours/week 
 
 
Table 4: Distribution of Physical Activity Status among PMS Cases and Controls (n=90) 
 Physical Activity 
Tertile 1 
N (% of tertile) 
Physical Activity 
Tertile 2 
N (% of tertile) 
Physical Activity 
Tertile 3 
N (% tertile) 
PMS Case 12 (19) 18 (28) 14 (23) 
PMS Control 17 (27) 16 (25) 13 (21) 
Total 29 (46) 34 (53) 27 (44) 
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Table 5: Distribution of Categorical Covariates According to PMS Status, among Cases 
and Controls (n=90)* 
PMS Case  
(n=44) 
PMS Control  
(n=46) 
 
N (%) N (%) 
 
P-value** 
Age 
18 
19-20 
21-22 
23-30 
 
6 (14) 
16 (36) 
13 (30) 
9 (20) 
 
9 (20) 
19 (41) 
10 (22) 
8 (17) 
 
 
0.74 
Age at first menses 
≤12 
>12 
 
25 (57) 
19 (43) 
 
20 (43) 
26 (57) 
 
0.21 
BMI (kg/m2) 
16.5-24.9 
≥25 
 
35 (80) 
9 (20) 
 
37 (80) 
9 (20) 
 
0.92 
Current alcohol intake (grams/day) 
0 
0.88-3.07 
3.08-7.92 
7.93-69.78 
 
5 (11) 
12 (27) 
15 (34) 
12 (27) 
 
11 (24) 
15 (32) 
10 (22) 
10 (22) 
 
 
0.29 
Hours of sleep per weeknight 
4-7 
≥8 
 
35 (80) 
9 (20) 
 
31 (67) 
15 (33) 
 
0.19 
Current oral contraceptive use 
Yes 
No 
 
19 (44) 
25 (56) 
 
17 (37) 
29 (63) 
 
0.55 
Ever Smoker 
Yes 
No 
 
13 (30) 
31 (70) 
 
2 (4) 
44  (96) 
 
0.001 
Marijuana use (any) 
Yes 
No 
 
14 (32) 
30 (68) 
 
8 (17) 
38 (83) 
 
0.11 
History of reproductive tract infections in the 
past 6 months 
Yes 
No 
 
 
2 (5) 
35 (79) 
 
 
2 (4) 
39 (85) 
 
 
0.38 
 
Previous diagnosis of depression or bipolar 
disorder 
Yes 
No 
 
 
8 (18) 
36 (82) 
 
 
4 (9) 
42 (91) 
 
 
0.19 
Vitamin D intake from food sources only 
(IU/day) 
<100 
≥100 
 
 
16 (36) 
28 (64) 
 
 
8 (17) 
38 (83) 
 
 
0.04 
Calcium intake from food sources only 
(mg/day) 
0-599 
600-1200 
>1200 
 
 
15 (34) 
20 (45) 
9 (21) 
 
 
6 (13) 
27 (59) 
13 (58) 
 
 
 
0.06 
Percent body fat measured with DEXA scan 
14.5-26.1 
26.2-31.6 
31.7-37.3 
37.4-50.1 
 
10 (23) 
13 (30) 
13 (30) 
7 (17) 
 
14 (30) 
12 (26) 
8 (18) 
12 (26) 
 
 
0.37 
*Numbers may not add up to 44 cases and 46 controls due to missing data 
**P-values from χ2 test and Fisher’s exact test (when cell sizes were <5) 
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Table 6: Distribution of Continuous Covariates According to PMS Status, among Cases 
and Controls (n=90) 
 Cases (n=44) 
Mean (SD) 
Controls (n=46) 
Mean (SD) 
P-value  
(Student’s t-test) 
Age (year) 21.9 (3.4) 21.5 (3.5) 0.56 
Age at first menses (year) 12.4 (1.4) 12.7 (1.2) 0.34 
BMI (kg/m2) 22.8 (2.9) 22.2 (3.2) 0.40 
Current alcohol intake (grams/day) 6.8 (6.8) 5.1 (7.8) 0.27 
Vitamin D intake from food sources only (IU/day) 188.4 (166.9) 209.6 (145.7) 0.52 
Calcium intake from food sources only (mg/day) 880.2 (377.4) 954.8 (383.2) 0.36 
Percent body fat  30.4 (7.3) 31.0 (8.4) 0.76 
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Table 7: Distribution of Covariates According to Physical Activity Status in all 
Participants (n=186)* 
Tertile 1 (n=62)  Tertile 2 (n=63) Tertile 3 (n=61) 
Median=16.1 
(MET-hrs/wk) 
Median=42.8 
(MET-hrs/wk) 
Median=100.3 
(MET-hrs/wk) 
 
N (%) N (%) N (%) 
 
P-value** 
Age 
18 
19-20 
21-22 
23-30 
 
11 (18) 
28 (45) 
9 (15) 
14 (22) 
 
9 (14) 
27 (43) 
13 (21) 
14 (22) 
 
8 (13) 
28 (46) 
17 (28) 
8 (13) 
 
 
0.54 
Age at first menses 
≤12 
>12 
 
36 (58) 
26 (42) 
 
35 (56) 
28 (44) 
 
26 (43) 
35 (57) 
 
0.18 
BMI (kg/m2) 
16.5-24.9 
≥25 
 
45 (74) 
16 (26) 
 
51 (81) 
12 (19) 
 
43 (70) 
18 (30) 
 
0.39 
Current alcohol intake (grams/day) 
0 
0.88-3.07 
3.08-7.92 
7.93-69.78 
 
10 (16) 
25 (40) 
11 (18) 
16 (26) 
 
16 (25) 
14 (22) 
17 (27) 
16 (25) 
 
13 (21) 
14 (23) 
18 (30) 
16 (26) 
 
 
0.25 
Hours of sleep per weeknight 
4-7 
≥8 
 
46 (74) 
16 (26) 
 
38 (60) 
25 (40) 
 
46 (77) 
14 (23) 
 
0.10 
Current oral contraceptive use 
Yes 
No 
 
24 (39) 
38 (61) 
 
32 (51) 
31 (49) 
 
17 (28) 
44 (72) 
 
0.03 
Ever Smoker 
Yes 
No 
 
8 (13) 
54 (87) 
 
11 (17) 
52 (83) 
 
5 (8) 
56 (92) 
 
0.31 
Marijuana use (any) 
Yes 
No 
 
16 (26) 
46 (74) 
 
16 (25) 
47 (75) 
 
14 (23) 
47 (77) 
 
0.92 
History of reproductive tract infections in 
the past 6 months 
Yes 
No 
 
 
4 (8) 
49 (92) 
 
 
4 (8) 
49 (92) 
 
 
2 (4) 
48 (96) 
 
 
0.77 
  
Previous diagnosis of depression or bipolar 
disorder 
Yes 
No 
 
 
10 (16) 
52 (84) 
 
 
8 (13) 
55 (87) 
 
 
5 (8) 
56 (92) 
 
 
0.41 
Vitamin D intake from food sources only 
(IU/day) 
<100 
≥100 
 
 
17 (27) 
45 (73) 
 
 
14 (22) 
49 (78) 
 
 
12 (20) 
49 (80) 
 
0.58 
Calcium intake from food sources only 
(mg/day) 
0-599 
600-1200 
>1200 
 
 
9 (14) 
40 (65) 
13 (21) 
 
 
14 (22) 
34 (54) 
15 (24) 
 
 
7 (11) 
26 (43) 
28 (46) 
 
0.01 
Percent body fat measured with DEXA scan 
14.5-26.1 
26.2-31.6 
31.7-37.3 
37.4-50.1 
 
12 (21) 
11( 19) 
15 (26) 
20 (34) 
 
16 (26) 
14 (23) 
17 (28) 
14 (23) 
 
14 (24) 
21 (36) 
13 (22) 
10 (17) 
 
 
0.24 
*Numbers may not add up to their respective tertile size due to missing data 
**P-values from χ2 test and Fisher’s exact test (when cell sizes were <5) 
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Table 8: Odds Ratios and 95% Confidence Intervals for the Association of Physical 
Activity and PMS, among Cases and Controls (n=90) 
  Unadjusted Multivariable* 
 Cases (N) Controls (N) OR 95% CI OR 95% CI 
Physical activity 
(Median) 
      
    Tertile 1 (16.1) 12 17 1.00 Referent 1.00 Referent 
    Tertile 2 (42.8) 18 16 1.59 0.59-4.33 1.62 0.58-4.51 
    Tertile 3 (100.3) 14 13 1.53 0.53-4.34 1.67 0.57-4.92 
 
   Unadjusted Multivariable* 
 Cases (N) Controls (N) OR 95% CI OR 95% CI 
Physical Activity 
(per 10 MET-
hours/week) 
 
44 
 
46 
 
1.03 
 
 
0.94-1.13 
 
1.03 
 
0.94-1.14 
*Adjusted for age and history of depression/bipolar disorder 
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Table 9: Multivariable* Odds Ratios and 95% Confidence Intervals for the Association of 
Physical Activity and PMS, with and without BMI and Percent Body Fat Included, 
among Cases and Controls (n=90) 
 Multivariable: 
Not including BMI 
or % body fat 
Multivariable: 
with BMI  
Multivariable: 
with % body fat  
Multivariable: 
with BMI and % 
body fat 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Physical 
activity 
        
    Tertile 1 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent 
    Tertile 2 1.62 0.58-4.51 1.67 0.59-4.68 1.73 0.60-4.95 1.71 0.59-4.94 
    Tertile 3 1.67 0.57-4.92 1.62 0.55-4.82 1.82 0.60-5.47 1.56 0.50-4.87 
 
 Multivariable: 
Not including BMI 
or % body fat 
Multivariable: 
with BMI  
Multivariable: 
with % body fat  
Multivariable: 
with BMI and % 
body fat 
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Continuous 
physical 
activity 
(per 10 MET-
hours/week) 
 
1.03 
 
0.94-1.14 
 
1.03 
 
0.94-1.14 
 
1.04 
 
0.94-1.14 
 
1.02 
 
0.93-1.13 
*Adjusted for age and history of depression/bipolar disorder
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Table 10: Multivariable* Odds Ratios and 95% Confidence Intervals for the Association 
of Physical Activity and PMS, by Category of BMI**, among Cases and Controls (n=90) 
 
 
Lower BMI 
<22.5 kg/m2 
Higher BMI 
≥22.5 kg/m2 
 OR 95% CI OR 95% CI 
Continuous 
physical activity 
(per 10 MET- 
hours/week) 
 
1.06        
 
0.90-1.26 
 
1.01 
 
0.89-1.15 
*Adjusted for age and history of depression/bipolar disorder 
**P-value for interaction = 0.68 
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Table 11: Multivariable* Odds Ratios and 95% Confidence Intervals of the Association 
Between Levels of Physical Activity** and Occurrence of Specific Menstrual 
Symptoms***, among All Participants (n=186) 
Symptom β  OR (95% CI) P-value 
Forgetfulness  0.10 1.10 (1.00-1.21) 0.04 
Food cravings  0.05 1.05 (0.99-1.11) 0.09 
Increased/decreased appetite 0.04 1.05 (0.99-1.11) 0.12 
Irritability  0.05 1.05 (0.99-1.11) 0.08 
Emotional hypersensitivity  0.05 1.05 (0.99-1.11) 0.07 
Dizziness 0.04 1.04 (0.92-1.17) 0.56 
Palpitations 0.04 1.04 (0.91-1.20) 0.55 
Mood swings  0.03 1.03 (0.98-1.09) 0.28 
Tendency to cry easily  0.03 1.03 (0.98-1.09) 0.28 
Swelling in extremities  0.03 1.03 (0.91-1.18) 0.63 
Breast tenderness 0.02 1.02 (0.97-1.08) 0.46 
Abdominal bloating 0.02 1.02 (0.96-1.08) 0.52 
Acne  0.01 1.02 (0.96-1.08) 0.63 
Depression 0.02 1.02 (0.93-1.12) 0.65 
Confusion 0.02 1.02 (0.89-1.17) 0.82 
Back pain  0.007 1.01 (0.94-1.07) 0.84 
Desire to be alone  0.006 1.01 (0.92-1.10) 0.90 
Insomnia  0.009 1.01 (0.90-1.13) 0.87 
Diarrhea/constipation  -0.003 1.00 (0.92-1.08) 0.95 
Anxiety/nervousness  0.00006 1.00 (0.91-1.10) 0.99 
Fatigue  -0.00998 0.99 (0.92-1.06) 0.78 
Abdominal cramping  -0.03 0.97 (0.91-1.03) 0.31 
Hot flashes  -0.07 0.93 (0.63-1.39) 0.73 
Angry outbursts  -0.11 0.89 (0.78-1.03) 0.12 
Nausea  -0.13 0.88 (0.69-1.11) 0.27 
Headache  -0.14 0.87 (0.74-1.01) 0.07 
*Adjusted for age and history of depression/bipolar disorder 
**OR per 10 MET-hour/week increase in physical activity 
***For each symptom, analysis compares moderate-severe vs. none-mild severity level 
 
 
 
  48 
REFERENCES 
 
(1) The American College of Obstetricians and Gynecologists. ACOG Education 
Pamphlet AP057. 2003; Available at: 
http://www.acog.org/publications/patient_education/bp057.cfm. Accessed 11/24, 2009. 
 
(2) Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors 
associated with premenstrual syndrome. Arch.Fam.Med. 1999 Mar-Apr;8(2):122-128. 
 
(3) Johnson SR. The epidemiology and social impact of premenstrual symptoms. 
Clin.Obstet.Gynecol. 1987 Jun;30(2):367-376. 
 
(4) Sternfeld B, Swindle R, Chawla A, Long S, Kennedy S. Severity of premenstrual 
symptoms in a health maintenance organization population. Obstet.Gynecol. 2002 
Jun;99(6):1014-1024. 
 
(5) Halbreich U. The etiology, biology, and evolving pathology of premenstrual 
syndromes. Psychoneuroendocrinology 2003 Aug;28 Suppl 3:55-99. 
 
(6) Daley A. Exercise and premenstrual symptomatology: a comprehensive review. 
J.Womens Health.(Larchmt) 2009 Jun;18(6):895-899. 
 
(7) Mortola JF. Assessment and management of premenstrual syndrome. 
Curr.Opin.Obstet.Gynecol. 1992 Dec;4(6):877-885. 
 
(8) Halbreich U, Backstrom T, Eriksson E, O'brien S, Calil H, Ceskova E, et al. Clinical 
diagnostic criteria for premenstrual syndrome and guidelines for their quantification for 
research studies. Gynecol.Endocrinol. 2007 Mar;23(3):123-130. 
 
(9) US Department of Health and Human Services, Hendrick V. Premenstrual Syndrome. 
2007; Available at: http://www.womenshealth.gov/faq/premenstrual-syndrome.pdf. 
 
(10) Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and 
premenstrual exacerbation of another disorder. Clin.Obstet.Gynecol. 2004 Sep;47(3):568-
575. 
 
(11) Aganoff JA, Boyle GJ. Aerobic exercise, mood states and menstrual cycle 
symptoms. J.Psychosom.Res. 1994 Apr;38(3):183-192. 
 
(12) Gannon L. The potential role of exercise in the alleviation of menstrual disorders 
and menopausal symptoms: a theoretical synthesis of recent research. Women Health 
1988;14(2):105-127. 
 
(13) Prior JC, Vigna Y. Conditioning exercise and premenstrual symptoms. 
J.Reprod.Med. 1987 Jun;32(6):423-428. 
  49 
 
(14) Choi PY, Salmon P. Symptom changes across the menstrual cycle in competitive 
sportswomen, exercisers and sedentary women. Br.J.Clin.Psychol. 1995 Sep;34 ( Pt 3)(Pt 
3):447-460. 
 
(15) Stoddard JL, Dent CW, Shames L, Bernstein L. Exercise training effects on 
premenstrual distress and ovarian steroid hormones. Eur.J.Appl.Physiol. 2007 
Jan;99(1):27-37. 
 
(16) Johnson WG, Carr-Nangle RE, Bergeron KC. Macronutrient intake, eating habits, 
and exercise as moderators of menstrual distress in healthy women. Psychosom.Med. 
1995 Jul-Aug;57(4):324-330. 
 
(17) Steege JF, Blumenthal JA. The effects of aerobic exercise on premenstrual 
symptoms in middle-aged women: a preliminary study. J.Psychosom.Res. 
1993;37(2):127-133. 
 
(18) Timonen S, Procope BJ. Premenstrual syndrome and physical exercise. Acta 
Obstet.Gynecol.Scand. 1971;50(4):331-337. 
 
(19) Prior JC, Vigna Y, Alojada N. Conditioning exercise decreases premenstrual 
symptoms. A prospective controlled three month trial. Eur.J.Appl.Physiol.Occup.Physiol. 
1986;55(4):349-355. 
 
(20) Prior JC, Vigna Y, Sciarretta D, Alojado N, Schulzer M. Conditioning exercise 
decreases premenstrual symptoms: a prospective, controlled 6-month trial. Fertil.Steril. 
1987 Mar;47(3):402-408. 
 
(21) Kritz-Silverstein D, Wingard DL, Garland FC. The association of behavior and 
lifestyle factors with menstrual symptoms. J.Womens Health.Gend.Based.Med. 1999 
Nov;8(9):1185-1193. 
 
(22) Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors 
associated with premenstrual syndrome. Arch.Fam.Med. 1999 Mar-Apr;8(2):122-128. 
 
(23) Rasheed P, Al-Sowielem LS. Prevalence and predictors of premenstrual syndrome 
among college-aged women in Saudi Arabia. Ann.Saudi Med. 2003 Nov-Dec;23(6):381-
387. 
 
(24) Masho SW, Adera T, South-Paul J. Obesity as a risk factor for premenstrual 
syndrome. J.Psychosom.Obstet.Gynaecol. 2005 Mar;26(1):33-39. 
 
(25) Rosenblatt PL,MD. Menstrual Cycle. 2007; Available at: 
http://www.merck.com/mmhe/sec22/ch241/ch241e.html. Accessed 1/29, 2010. 
 
  50 
(26) Hypothalamic–pituitary–adrenal axis. Available at: 
http://en.wikipedia.org/wiki/Hypothalamic–pituitary–adrenal_axis. 
 
(27) The Lundbeck Institute. The hypothalamic-pituitary-adrenal (HPA) axis. 2005; 
Available at: 
http://www.cnsforum.com/imagebank/item/HPA_NORM_DPN_3/default.aspx. 
 
(28) Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, et al. 
Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women 
with premenstrual syndrome and controls. J.Clin.Endocrinol.Metab. 2003 
Jul;88(7):3057-3063. 
 
(29) Watts JF, Butt WR, Logan Edwards R, Holder G. Hormonal studies in women with 
premenstrual tension. Br.J.Obstet.Gynaecol. 1985 Mar;92(3):247-255. 
 
(30) Woods NF, Most A, Longenecker GD. Major life events, daily stressors, and 
perimenstrual symptoms. Nurs.Res. 1985 Sep-Oct;34(5):263-267. 
 
(31) Ainsworth BE, Haskell WL, Leon AS, Jacobs DR,Jr, Montoye HJ, Sallis JF, et al. 
Compendium of physical activities: classification of energy costs of human physical 
activities. Med.Sci.Sports Exerc. 1993 Jan;25(1):71-80. 
 
(32) Wolf AM, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Corsano KA, et al. 
Reproducibility and validity of a self-administered physical activity questionnaire. 
Int.J.Epidemiol. 1994 Oct;23(5):991-999. 
 
(33) Mortola JF, Girton L, Beck L, Yen SS. Diagnosis of premenstrual syndrome by a 
simple, prospective, and reliable instrument: the calendar of premenstrual experiences. 
Obstet.Gynecol. 1990 Aug;76(2):302-307. 
 
(34) Bertone-Johnson ER, Hankinson SE, Johnson SR, Manson JE. A simple method of 
assessing premenstrual syndrome in large prospective studies. J.Reprod.Med. 2007 
Sep;52(9):779-786. 
 
(35) Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical 
activity and public health: updated recommendation for adults from the American 
College of Sports Medicine and the American Heart Association. Med.Sci.Sports Exerc. 
2007 Aug;39(8):1423-1434. 
 
 
 
 
 
 
